Your browser doesn't support javascript.
loading
Who should be prioritized for COVID-19 vaccination in China? A descriptive study.
Yang, Juan; Zheng, Wen; Shi, Huilin; Yan, Xuemei; Dong, Kaige; You, Qian; Zhong, Guangjie; Gong, Hui; Chen, Zhiyuan; Jit, Mark; Viboud, Cecile; Ajelli, Marco; Yu, Hongjie.
Afiliação
  • Yang J; School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.
  • Zheng W; School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.
  • Shi H; School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.
  • Yan X; School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.
  • Dong K; School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.
  • You Q; School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.
  • Zhong G; School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.
  • Gong H; School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.
  • Chen Z; School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.
  • Jit M; Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.
  • Viboud C; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
  • Ajelli M; WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Special Administrative Region, Hong Kong, China.
  • Yu H; Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, MD, USA.
BMC Med ; 19(1): 45, 2021 02 10.
Article em En | MEDLINE | ID: mdl-33563270
ABSTRACT

BACKGROUND:

All countries are facing decisions about which population groups to prioritize for access to COVID-19 vaccination after the first vaccine products have been licensed, at which time supply shortages are inevitable. Our objective is to define the key target populations, their size, and priority for a COVID-19 vaccination program in the context of China.

METHODS:

On the basis of utilitarian and egalitarian principles, we define and estimate the size of tiered target population groups for a phased introduction of COVID-19 vaccination, considering evolving goals as vaccine supplies increase, detailed information on the risk of illness and transmission, and past experience with vaccination during the 2009 influenza pandemic. Using publicly available data, we estimated the size of target population groups, and the number of days needed to vaccinate 70% of the target population. Sensitivity analyses considered higher vaccine coverages and scaled up vaccine delivery relative to the 2009 pandemic.

RESULTS:

Essential workers, including staff in the healthcare, law enforcement, security, nursing homes, social welfare institutes, community services, energy, food and transportation sectors, and overseas workers/students (49.7 million) could be prioritized for vaccination to maintain essential services in the early phase of a vaccination program. Subsequently, older adults, individuals with underlying health conditions and pregnant women (563.6 million) could be targeted for vaccination to reduce the number of individuals with severe COVID-19 outcomes, including hospitalizations, critical care admissions, and deaths. In later stages, the vaccination program could be further extended to target adults without underlying health conditions and children (784.8 million), in order to reduce symptomatic infections and/or to stop virus transmission. Given 10 million doses administered per day, and a two-dose vaccination schedule, it would take 1 week to vaccinate essential workers but likely up to 7 months to vaccinate 70% of the overall population.

CONCLUSIONS:

The proposed framework is general but could assist Chinese policy-makers in the design of a vaccination program. Additionally, this exercise could be generalized to inform other national and regional strategies for use of COVID-19 vaccines, especially in low- and middle-income countries.
Assuntos
Palavras-chave

Texto completo: 1 Temas: ECOS / Estado_mercado_regulacao Bases de dados: MEDLINE Assunto principal: Polícia / Pessoal de Saúde / Programas de Imunização / Seleção de Pacientes / Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Aged / Child / Female / Humans / Infant / Male / Middle aged / Pregnancy País/Região como assunto: Asia Idioma: En Revista: BMC Med Assunto da revista: MEDICINA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Temas: ECOS / Estado_mercado_regulacao Bases de dados: MEDLINE Assunto principal: Polícia / Pessoal de Saúde / Programas de Imunização / Seleção de Pacientes / Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Aged / Child / Female / Humans / Infant / Male / Middle aged / Pregnancy País/Região como assunto: Asia Idioma: En Revista: BMC Med Assunto da revista: MEDICINA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China